NeuroSense Therapeutics Ltd - Warrants (09/11/2026) OverviewNeuroSense Therapeutics Ltd - Warrants (09/11/2026) EBIT
EBIT (Earnings Before Interest and Taxes) analysis for NRSNW.
Quarterly EBIT
-$2.35M
↑ 22.57% YoY
As of Jun 30, 2025
Annual EBIT (TTM)
-$8.57M
↑ 29.8% YoY
Trailing 12 months ending Jun 30, 2025